Literature DB >> 10883004

Exercise test in muscle channelopathies and other muscle disorders.

T Kuntzer1, F Flocard, C Vial, A Kohler, M Magistris, A Labarre-Vila, P M Gonnaud, F Ochsner, P Soichot, V Chan, G Monnier.   

Abstract

We studied the percentage change in compound muscle action potential (CMAP) amplitude and area during and after a 5-min maximal contraction of the muscle. The exercise test (ET) was performed on 64 patients with different muscle disorders and on 46 normal controls. The range of normal ET values was defined as the mean + 2 SD of the control values. The mean sensitivity of the test was 63% in the whole group with ion channel muscle disorders, the highest sensitivity being seen in primary periodic paralysis (81%) and the lowest in chloride channelopathies (17%). In thyrotoxic periodic paralysis, the ET was abnormal in the three of the four patients studied. In patients with myotonic dystrophy, a smaller than normal increase in CMAP amplitude occurred during and after exercise, whereas in proximal myotonic myopathy a normal initial increase in CMAP amplitude was followed by an abnormal decrement. We conclude that the ET can be of use in confirming abnormal muscle membrane excitability in patients with calcium and sodium channelopathies and thyrotoxic periodic paralysis. In chloride channelopathy, the test may also be abnormal, but shows no, or only a small, increase in amplitude or area in the immediate postexercise period. The test may also be abnormal in proximal myotonic myopathy, but is normal in myotonic dystrophy. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10883004     DOI: 10.1002/1097-4598(200007)23:7<1089::aid-mus12>3.0.co;2-q

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  12 in total

1.  Effect of membrane properties on skeletal muscle fiber excitability: a sensitivity analysis.

Authors:  Emma Fortune; Madeleine M Lowery
Journal:  Med Biol Eng Comput       Date:  2012-03-20       Impact factor: 2.602

2.  Renal, ocular, and neuromuscular involvements in patients with CLDN19 mutations.

Authors:  Stanislas Faguer; Dominique Chauveau; Pascal Cintas; Ivan Tack; Olivier Cointault; Lionel Rostaing; Rosa Vargas-Poussou; David Ribes
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 8.237

3.  Phenotypic variation of Val1589Met mutation in a four-generation Chinese pedigree with mild paramyotonia congenitia: case report.

Authors:  Changshui Xu; Junjia Qi; Yingying Shi; Yan Feng; Weizhou Zang; Jiewen Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 4.  Guidelines on clinical presentation and management of nondystrophic myotonias.

Authors:  Bas C Stunnenberg; Samantha LoRusso; W David Arnold; Richard J Barohn; Stephen C Cannon; Bertrand Fontaine; Robert C Griggs; Michael G Hanna; Emma Matthews; Giovanni Meola; Valeria A Sansone; Jaya R Trivedi; Baziel G M van Engelen; Savine Vicart; Jeffrey M Statland
Journal:  Muscle Nerve       Date:  2020-05-27       Impact factor: 3.217

5.  In vivo and in vitro functional characterization of Andersen's syndrome mutations.

Authors:  Saïd Bendahhou; Emmanuel Fournier; Damien Sternberg; Guillaume Bassez; Alain Furby; Carole Sereni; Matthew R Donaldson; Marie-Madeleine Larroque; Bertrand Fontaine; Jacques Barhanin
Journal:  J Physiol       Date:  2005-04-14       Impact factor: 5.182

6.  Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies.

Authors:  S Veronica Tan; Emma Matthews; Melissa Barber; James A Burge; Sanjeev Rajakulendran; Doreen Fialho; Richa Sud; Andrea Haworth; Martin Koltzenburg; Michael G Hanna
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

Review 7.  Hypokalemic periodic paralysis: a model for a clinical and research approach to a rare disorder.

Authors:  Bertrand Fontaine; Emmanuel Fournier; Damien Sternberg; Savine Vicart; Nacira Tabti
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 8.  Clinical evaluation of membrane excitability in muscle channel disorders: potential applications in clinical trials.

Authors:  James C Cleland; Eric L Logigian
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

9.  Bidirectional ventricular tachycardia of unusual etiology.

Authors:  Praloy Chakraborty; Bhavna Kaul; Kausik Mandal; H S Isser; Sandeep Bansal; Anandaraja Subramanian
Journal:  Indian Pacing Electrophysiol J       Date:  2016-02-23

10.  Concomitant presentation of Anderson-Tawil syndrome and myasthenia gravis in an adult patient: A case report.

Authors:  Rui Fan; Ruirui Ji; Wenxin Zou; Guoliang Wang; Hu Wang; Daniel James Penney; Jin Jun Luo; Yuxin Fan
Journal:  Exp Ther Med       Date:  2016-09-06       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.